MYC and neoplasm: Thus, mutations in components of the WNT/β-catenin signaling pathway induce aberrant MYC expression and, because of that, increased expression of the immune checkpoint proteins PD-L1 and CD47 and a non-T cell-inflamed tumor phenotype.